Literature DB >> 1347074

Expression of oestrogen receptor and transforming growth factor-alpha in MCF-7 cells after exposure to fractionated irradiation.

R K Schmidt-Ullrich1, K Valerie, W Chan, D E Wazer, P S Lin.   

Abstract

The expression of critical growth controlling genes was studied in MCF-7 cells after exposure to cumulative radiation doses of 20 and 60 Gy yielding cell lines called MCF-IR-1 and MCF-IR-3, respectively. The irradiated cell lines exhibited increased plating efficiencies but no differences in growth rates. MCF-IR-1/-IR-3 cells showed a reduced oestrogen responsiveness as indicated by their diminished response to tamoxifen-induced growth arrest and 17 beta-oestradiol (E2)-induced growth stimulation. The reduced expression of oestrogen receptor (ER) was determined by quantitative immune peroxidase staining of single cells and by total cellular E2 binding. There was also a radiation dose-dependent increase in the radiosensitivity of MCF-IR-3 cells as determined by the radiobiological parameters alpha, beta, and D (mean inactivation dose). Using RNA protection assays the irradiated cell lines produced steady-state ER mRNA at reduced levels while the levels of TGF-alpha were unchanged in MCF-IR-1 cells but increased 2.8-fold in MCF-IR-3 cells. A similar pattern was seen for TGF-alpha protein. While the current analyses cannot differentiate between radiation-induced altered gene expression or cell selection the results demonstrate that reduced ER expression and increased TGF-alpha expression are associated with the survival of MCF-7 cells after fractionated irradiation in vitro. In contrast, the MCF-IR cells were found to be more radiosensitive in acute survival experiments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347074     DOI: 10.1080/09553009214551101

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  8 in total

Review 1.  Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.

Authors:  Ifigeneia V Mavragani; Danae A Laskaratou; Benjamin Frey; Serge M Candéias; Udo S Gaipl; Katalin Lumniczky; Alexandros G Georgakilas
Journal:  Toxicol Res (Camb)       Date:  2015-08-11       Impact factor: 3.524

2.  Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death.

Authors:  P Dent; D B Reardon; J S Park; G Bowers; C Logsdon; K Valerie; R Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 3.  Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

Authors:  Juliette Thariat; Gokcen Yildirim; Kathryn A Mason; Adam S Garden; Luka Milas; K Kian Ang
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

Review 4.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

5.  An in vitro model of epithelial cell growth stimulation in the rodent mammary gland.

Authors:  U K Ehmann; J T DeVries; M S C Chen; A A Adamos; R C Guzman; M B Omary
Journal:  Cell Prolif       Date:  2003-08       Impact factor: 6.831

Review 6.  Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.

Authors:  Edward Rustamzadeh; Chunbin Li; Sekou Doumbia; Walter A Hall; Daniel A Vallera
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

7.  Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib.

Authors:  Hua Cheng; She-Juan An; Song Dong; Yi-Fang Zhang; Xu-Chao Zhang; Zhi-Hong Chen; Yi-Long Wu
Journal:  J Hematol Oncol       Date:  2011-01-21       Impact factor: 17.388

8.  Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.

Authors:  Valentina Bravatà; Claudia Cava; Luigi Minafra; Francesco Paolo Cammarata; Giorgio Russo; Maria Carla Gilardi; Isabella Castiglioni; Giusi Irma Forte
Journal:  Int J Mol Sci       Date:  2018-04-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.